A Novel Analytical Method for the Simultaneous Estimation of Remogliflozin and Metformin Hydrochloride

Authors

  • Abhishek Jain
  • Prakash Jain

Abstract

Specific and novel strategy has been improved for assessment of Remogliflozin and Metformin hydrochloride in mass and plan and cleaning tests by UPLC-PDA. The scientific method was the phosphate Buffer (pH: 4.5): Acetonitrile, (60:40%, v/v) utilizing the spherisorb C18, 5 µm, 4.6 mm×150 mm insightful segment with investigation season of 5 min. The progression of versatile stage through section was 1.0 ml/min. The test volume was 10 µl. The discovery was conveyed at 245 nm in photograph diode exhibit indicator. The maintenance seasons of Remogliflozin and Metformin hydrochloride were 3.017 and 5.011 min. The bend demonstrates relationship coefficient (r2) was prevalent by having the worth 1.000 with straight scope of 10–100.0 ng/ml for Remogliflozin; and for Metformin hydrochloride, it was 50–500.0 ng/ml. The connection coefficient (r2) for Metformin hydrochloride was discovered to be 1.000. The LOQ for the Remogliflozin and Metformin hydrochloride was 10 and 50 ng/ml, and the LOD for the Remogliflozin and Metformin hydrochloride was 5 and 10 ng/ml. The created technique was applied for the mass and detailing and cleaning test.

 

Keywords: Remogliflozin, Metformin hydrochloride, bulk drug, formulation, cleaning samples, UPLC-PDA

 

Cite this Article

Abhishek Jain, Prakash Jain. A Novel Analytical Method for the Simultaneous Estimation of Remogliflozin and Metformin Hydrochloride. Research & Reviews: A Journal of Drug Formulation, Development and Production. 2020; 7(3): 1–15p.

Downloads

Published

2021-01-16

Issue

Vol. 7 No. 3 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.